Cargando…
The Comprehensive Analysis of Specific Proteins as Novel Biomarkers Involved in the Diagnosis and Progression of Gastric Cancer
Gastric cancer (GC) cases are predicted to rise by 2040 to approximately 1.8 million cases, while GC-caused deaths to 1.3 million yearly worldwide. To change this prognosis, there is a need to improve the diagnosis of GC patients because this deadly malignancy is usually detected at an advanced stag...
Autores principales: | Pawluczuk, Elżbieta, Łukaszewicz-Zając, Marta, Mroczko, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218496/ https://www.ncbi.nlm.nih.gov/pubmed/37240178 http://dx.doi.org/10.3390/ijms24108833 |
Ejemplares similares
-
The Role of Chemokines in the Development of Gastric Cancer—Diagnostic and Therapeutic Implications
por: Pawluczuk, Elzbieta, et al.
Publicado: (2020) -
Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer
por: Pawluczuk, Elżbieta, et al.
Publicado: (2021) -
Circulating Biomarkers of Colorectal Cancer (CRC)—Their Utility in Diagnosis and Prognosis
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021) -
A Disintegrin and Metalloproteinase (ADAM) Family—Novel Biomarkers of Selected Gastrointestinal (GI) Malignancies?
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2022) -
CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression
por: Pączek, Sara, et al.
Publicado: (2020)